Seastar Investor
reacted to and commented on
$SeaStar Medical (ICU.US)$
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
SeaStar Medical Holding (Nasdaq: ICU) reports progress in its pivotal NEUTRALIZE-AKI trial, with four new subjects enrolled in 10 days, bringing total enrollment to 46. The trial evaluates the company's Selective Cytopheretic Device (SCD) for adults with acute kidney injury (AKI) in ICU receiving continuous kidney replacement therapy (CKRT).
Key points:
Trial aims to enroll up to 200 adul...
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
SeaStar Medical Holding (Nasdaq: ICU) reports progress in its pivotal NEUTRALIZE-AKI trial, with four new subjects enrolled in 10 days, bringing total enrollment to 46. The trial evaluates the company's Selective Cytopheretic Device (SCD) for adults with acute kidney injury (AKI) in ICU receiving continuous kidney replacement therapy (CKRT).
Key points:
Trial aims to enroll up to 200 adul...
4
2
Seastar Investor
reacted to
3
Seastar Investor
reacted to
$SeaStar Medical (ICU.US)$ on high watch
3